A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trialGilberto de Castro, Nils Gunnar Skare, Sérgio Jobim Azevedo et al.|European Journal of Cancer|2017Cited by 57